ARTICLE | Clinical News
Synta preclinical data
December 21, 2009 8:00 AM UTC
In AML cell lines in vitro, elesclomol displayed potent anti-leukemic effects at concentrations as low as 10 nM. Data were presented at the American Society of Hematology meeting in New Orleans. In Ma...